Danaher Corporation (DHR): Rep. Robert P. Bresnahan Jr. (PA08) disclosed a sale $1K–$15K
Rep. Robert P. Bresnahan Jr. (PA08) disclosed a sale of Danaher Corporation in the $1K–$15K range.
- $1,001–$15,000
- Reported range · official band, not an exact amount
- 16 days
- Disclosure lag
- Traded
- May 15, 2025
- Disclosed
- May 31, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- May 8, 2015CongressDisclosed purchase of DHR — reported range $15,001 - $50,000
- Oct 29, 2024CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
- Feb 25, 2025CongressDisclosed sale of DHR — reported range $15,001 - $50,000
- Mar 4, 2025CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
- Mar 27, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
- Apr 7, 2025CongressDisclosed sale of DHR — reported range $15,001 - $50,000
- Apr 8, 2025CongressDisclosed purchase of DHR — reported range $15,001 - $50,000
- Apr 11, 2025CongressDisclosed partial sale of DHR — reported range $1,001 - $15,000
- Apr 21, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
- Apr 30, 2025Insider · 1 personInsiders: 2 sales (~$3.1M)
- May 12, 2025Insider · 1 personInsiders: 8 sales (~$245.9M)
- May 12, 2025CongressDisclosed sale of DHR — reported range $15,001 - $50,000
- May 15, 2025 · this disclosureCongressDisclosed sale of DHR — reported range $1,001 - $15,000
What came next
- Jun 11, 2025CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
- Jun 12, 2025CongressDisclosed sale of DHR — reported range $50,001 - $100,000
- Jul 22, 2025CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
- Jul 24, 2025FDARecall: MicroScan Neg MIC 56 REF C42464 UDI-DI code: 15099590731212 MicroScan panels are designed for use in determining antimicrobial agent susceptibility and/or iden…
- Aug 1, 2025FDAFDA device clearance: Access hsTnI
- Aug 4, 2025FDARecall: DxC 500 AU Module w/ISE, DxC 500i, With ISE, REF: C63522 and DxC 500 AU Module, DxC 500i, Without ISE, REF: C6352; part of the DxC 500i Clinical Analyzer
- Aug 6, 2025FDARecall: Xpert SA Nasal Complete Catalog Number: GXSACOMP-10 UDI-DI code: 07332940000158 Xpert SA Nasal Complete kit; 10 test kit: A collection of reagents and other as…
- Aug 13, 2025FDARecall: UniCel DxH 800 COULTER Cellular Analysis System, configured with the Led HGB Photometer REFs:B24802, 629029, B63322
- Aug 13, 2025FDARecall: UniCel DxH 900 COULTER Cellular Analysis System, configured with the Led HGB Photometer REF: C11478
- Aug 13, 2025FDARecall: UniCel DxH 690T COULTER Cellular Analysis System, configured with the Led HGB Photometer REF: C34520
- Aug 13, 2025FDARecall: UniCel DxH 600 COULTER Cellular Analysis System, configured with the Led HGB Photometer REF:B23858
- Aug 15, 2025FDAFDA device clearance: MicroScan Dried Gram-Positive MIC/Combo Panels with Daptomycin (DAP) (0.06-32 µg/mL)
- Aug 20, 2025FDAFDA device clearance: MicroScan Dried Gram-Negative MIC/Combo Panels with Cefepime (CPE) (0.12-64 µg/mL) (MicroScan)
- Aug 22, 2025InsiderDirector sold ~$586K of DHR shares in the open market
- Aug 28, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
- Sep 3, 2025FDARecall: SYNCHRON Systems Phosphorus (PHOSm) Reagent REF: 467868 For In Vitro Diagnostic Use, Rx Only.
- Sep 8, 2025FDARecall: CellMek SPS Sample Preparation System, REF: C44603. Software versions 2.2.122.0 and prior, and Instructions for Use (IFU) revisions AD and prior. These CellMek…
- Sep 8, 2025FDARecall: MicroScan Neg Multidrug Resistant MIC 1 REF C32368 UDI-DI code: 15099590720568 Intended Use- For use with MicroScan Dried Gram Negative MIC/Combo Panels and Dr…
- Sep 9, 2025Company filing · Form 8-K · Bylaws or charter, Other newsChanged its bylaws, charter or fiscal year, and reported other company news
- Sep 9, 2025FDAFDA device clearance: Access anti-HAV
How to read House Clerk periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Danaher Corporation
For Danaher Corporation, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports and 2 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DHR page.
Other recent filings by Rep. Robert P. Bresnahan Jr. (PA08)
- House Clerk periodic transaction report at Berkshire Hathaway (BRK.B)Dec 19, 2025
- House Clerk periodic transaction report at Gitlab (GTLB)Jul 8, 2025
- House Clerk periodic transaction report at Amazon (AMZN)Jul 8, 2025
- House Clerk periodic transaction report at AppLovin (APP)Jul 8, 2025
- House Clerk periodic transaction report at Atlassian (TEAM)Jul 8, 2025
The full history of Rep. Robert P. Bresnahan Jr. (PA08) is on the profile page.
How this filing works
Explore the data
Other disclosures at Danaher Corporation
- SEC Form 144Nov 10, 2026
- SEC Form 4Nov 10, 2026
- SEC Form 4Nov 10, 2026
- SEC Form 144Nov 9, 2026
- SEC Form 144Nov 9, 2026
- SEC Form 144Nov 9, 2026
Everything OQRO holds on this company is on its DHR page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
